Sector Gamma AS’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.11M Buy
75,000
+13,077
+21% +$926K 1.21% 28
2025
Q4
$4.7M Sell
61,923
-56,189
-48% -$4.08M 1.07% 32
2025
Q3
$7.25M Buy
118,112
+25,862
+28% +$1.35M 1.8% 21
2025
Q2
$4.51M Hold
92,250
1.47% 25
2025
Q1
$4.7M Buy
92,250
+27,000
+41% +$1.35M 1.51% 24
2024
Q4
$2.95M Buy
+65,250
New +$2.79M 1.01% 26
2023
Q3
Sell
-56,577
Closed -$2.3M 30
2023
Q2
$2.3M Buy
56,577
+1,671
+3% +$81.8K 0.51% 29
2023
Q1
$2.66M Sell
54,906
-31,786
-37% -$1.45M 0.64% 31
2022
Q4
$3.31M Hold
86,692
0.76% 27
2022
Q3
$4.35M Buy
86,692
+1,828
+2% +$89.6K 1.12% 22
2022
Q2
$3.4M Buy
84,864
+5,000
+6% +$175K 0.76% 28
2022
Q1
$2.98M Buy
+79,864
New +$3.08M 0.65% 33
2020
Q3
Sell
-90,396
Closed -$4.59M 32
2020
Q2
$4.59M Buy
90,396
+14,400
+19% +$708K 0.95% 29
2020
Q1
$3.39M Sell
75,996
-24,206
-24% -$1.22M 0.72% 28
2019
Q4
$4.81M Sell
100,202
-21,200
-17% -$901K 0.77% 31
2019
Q3
$4.11M Sell
121,402
-108,096
-47% -$4.7M 0.69% 30
2019
Q2
$10.3M Buy
229,498
+34,755
+18% +$1.37M 1.66% 20
2019
Q1
$7.33M Buy
+194,743
New +$6.54M 1.18% 25

Other funds holding PTCT

Sector Gamma AS's PTCT Position: Q1 2026 in Review

Sector Gamma AS increased its PTC Therapeutics (PTCT) stake by 21% in Q1 2026, buying an estimated $926K and bringing the position to 75,000 shares worth $5.11M. The position accounts for 1.21% of the portfolio, ranked #28.

Sector Gamma AS first reported a position in PTCT in Q1 2019 and has held it in 18 quarters since. The position peaked at $10.3M in Q2 2019. 349 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • Sector Gamma AS held 75,000 shares of PTC Therapeutics worth $5.11M as of Q1 2026.
  • Sector Gamma AS bought 13,077 PTC Therapeutics shares in Q1 2026, an estimated $926K.
  • PTC Therapeutics made up 1.21% of Sector Gamma AS's portfolio in Q1 2026, its #28 holding.
  • Sector Gamma AS first reported a position in PTC Therapeutics in Q1 2019 and has held it in 18 quarters since.
  • Sector Gamma AS's PTC Therapeutics position peaked at $10.3M in Q2 2019.
  • 349 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on Sector Gamma AS's 13F filing for Q1 2026, filed 7 May 2026.